FindTrial
Sign In

CYTALUX™ (pafolacianine)

DRUG2 trials

Sponsors

Cedars-Sinai Medical Center, Abramson Cancer Center at Penn Medicine

Conditions

Appendiceal CancerCYTALUX (Pafolacianine) InjectionEndometrial CancerEsophageal CancerGastric CancerGastrointestinal CancerNear Infrared Fluorescence ImagingPlanned Diagnostic Laparoscopies

Early Phase 1

CYTALUX for Intraoperative Imaging of Patients With Endometrial Cancer
RecruitingNCT07278986
Abramson Cancer Center at Penn MedicineCYTALUX (Pafolacianine) Injection, Endometrial Cancer, Near Infrared Fluorescence Imaging +1
Start: 2025-10-18End: 2029-02-28Target: 10Updated: 2025-12-12

Phase 4

Intraoperative Imaging of Gastrointestinal Malignancies Using Pafolacianine (CYTALUX™)
RecruitingNCT07124351
Cedars-Sinai Medical CenterAppendiceal Cancer, Esophageal Cancer, Gastric Cancer +1
Start: 2025-09-05End: 2026-09-30Target: 15Updated: 2025-09-15